Annual Total Long Term Liabilities
$38.30 K
+$38.30 K+100.00%
01 December 2023
Summary:
TransCode Therapeutics annual total long term liabilities is currently $38.30 thousand, with the most recent change of +$38.30 thousand (+100.00%) on 01 December 2023. During the last 3 years, it has risen by +$38.30 thousand (+100.00%). RNAZ annual total long term liabilities is now -99.06% below its all-time high of $4.06 million, reached on 31 December 2020.RNAZ Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
01 September 2024
Summary:
TransCode Therapeutics quarterly total long term liabilities is currently $0.00, unchanged on 01 September 2024. Over the past year, it has dropped by -$38.30 thousand (-100.00%). RNAZ quarterly long term liabilities is now -100.00% below its all-time high of $8.09 million, reached on 31 March 2021.RNAZ Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -100.0% |
| 3 y3 years | +100.0% | 0.0% |
| 5 y5 years | -96.9% | - |
RNAZ Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | ||
| 5 y | 5 years | -99.1% | -100.0% | ||
| alltime | all time | -99.1% | -100.0% |
TransCode Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $38.30 K(>+9900.0%) | $38.30 K(-79.8%) |
| Sept 2023 | - | $189.80 K(-28.6%) |
| June 2023 | - | $265.70 K(-29.7%) |
| Mar 2023 | - | $377.80 K(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(-100.0%) |
| June 2021 | - | $5.03 M(-37.9%) |
| Mar 2021 | - | $8.09 M(+99.4%) |
| Dec 2020 | $4.06 M(+224.4%) | - |
| Dec 2020 | - | $4.06 M |
| Dec 2019 | $1.25 M | - |
FAQ
- What is TransCode Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly long term liabilities year-on-year change?
What is TransCode Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RNAZ is $38.30 K
What is the all time high annual total long term liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total long term liabilities is $4.06 M
What is TransCode Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RNAZ is $0.00
What is the all time high quarterly long term liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total long term liabilities is $8.09 M
What is TransCode Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RNAZ quarterly total long term liabilities has changed by -$38.30 K (-100.00%)